EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative transcriptomic and single-nucleus analyses identify microbiota–metabolite-associated immune signatures of fibrosis severity in MASLD

Zhi-Yun Liu, Jing Feng, Wen-Qiao Lu, Lin Wang, Qian-Yu Bi, Jie Gao, Chun-Lei Liu, Te-Jin Ba, Li Kong, Fei-Hu Zhang iD

PLOS One · 16.11.2026 · 21 (11) · e0362860

DOI: 10.1371/journal.pone.0362860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 16.11.2026. Verfasst von Zhi-Yun Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Transcriptome, Microbiota. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study has been supported by a research grant from Shandong Province Medical and Health Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To identify microbiota–metabolite-associated immune features associated with fibrosis severity and evaluate their cross-cohort expression, discrimination and cellular context in human liver.

Methods

Discovery used 206 NAFLD cases from GSE135251, comparing F0–F2 with F3–F4. Human gutMGene host genes were intersected with ImmPort immune genes, followed by transcriptome-wide FDR filtering, LASSO and balanced Random Forest selection. Complete-pipeline five-fold cross-validation assessed internal performance. Fixed features and coefficients were evaluated in GSE130970, including age- and sex-adjusted sensitivity analyses. GSE244832 provided single-nucleus localization and descriptive CellChat context.

Results

Discovery identified 721 global differentially expressed genes and 23 candidates from a 72-gene biological prior. Eight features were selected: CCL2 , MYC , CASP1 , CAT , DEFB1 , NLRP6 , HMOX1 and SMURF2 . Apparent discovery AUC was 0.859, full-pipeline out-of-fold AUC was 0.805, and fixed-processing external AUC was 0.808 (95% CI, 0.670–0.946). Five features showed concordant external differences after multiple-testing correction; four remained significant after age–sex adjustment. SMURF2 showed an opposite association. The fixed score remained associated with F3–F4 after adjustment (OR 3.09; 95% CI, 1.49–6.42). CASP1 / HMOX1 localized predominantly to Macrophage/Kupffer cells and CCL2 to Fibroblast/Stellate cells; NLRP6 was sparsely detected. Donor-level differences were not significant after correction.

Conclusions

The exploratory signature showed retrospective cross-cohort discrimination with heterogeneous gene-level support. Cellular localization and inferred communication provide biological context. Limited clinical covariates, external sample size, measurement differences and probability calibration restrict clinical interpretation. Prospective and experimental validation are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisTranscriptomeMicrobiotaHumansFemaleGene Expression ProfilingMaleCell Nucleus

Autor:innen und Institutionen

  • Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Emergency Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Emergency and Critical Care Medicine, International Mongolian Medical Hospital of Inner Mongolia Autonomous Region, Hohhot, China.

ORCID-Profile: Fei-Hu Zhang

Förderung

  • This study has been supported by a research grant from Shandong Province Medical and Health Technology Project

Zitieren

APA

Liu, Z. Y., Feng, J., Lu, W. Q., Wang, L., Bi, Q. Y., Gao, J., Liu, C. L., Ba, T. J., Kong, L., & Zhang, F. H. (2026). Integrative transcriptomic and single-nucleus analyses identify microbiota–metabolite-associated immune signatures of fibrosis severity in MASLD. PLOS One, 21(11), e0362860. https://doi.org/10.1371/journal.pone.0362860

Vancouver

Liu ZY, Feng J, Lu WQ, Wang L, Bi QY, Gao J, et al. Integrative transcriptomic and single-nucleus analyses identify microbiota–metabolite-associated immune signatures of fibrosis severity in MASLD. PLOS One. 2026;21(11):e0362860. doi:10.1371/journal.pone.0362860

BibTeX
@article{Liu2026,
  author = {Liu, Zhi-Yun and Feng, Jing and Lu, Wen-Qiao and Wang, Lin and Bi, Qian-Yu and Gao, Jie and Liu, Chun-Lei and Ba, Te-Jin and Kong, Li and Zhang, Fei-Hu},
  title = {Integrative transcriptomic and single-nucleus analyses identify microbiota–metabolite-associated immune signatures of fibrosis severity in MASLD},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0362860},
  doi = {10.1371/journal.pone.0362860}
}
Kostenlos starten →